| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |